InnoPharmax Net Tangible Assets

The latest net tangible assets for 4172.TWO is $530M as of June 2026. That compares with $550M in the prior-year period — down 4.2% year over year. Investors often review this figure alongside InnoPharmax's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4172.TWO's net tangible assets moved from $550M to $530M — a 4.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InnoPharmax's operating scale or balance-sheet position.

A net tangible assets figure of $530M for 4172.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4172.TWO's net tangible assets ($530M), review year-over-year change from $550M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.